Regulatory product record
FURAZONE DRESSING
Product identity, ingredients and source provenance from the regulatory catalogue. Linked clinical evidence has a separate review status.
Product identity
- Brand name
- FURAZONE DRESSING
- DIN
- 02311917
- DPD drug code
- 79745
- Regulatory category
- APPROVED_VET_DRUG
- Market status
- MARKETED
- Route(s)
- TOPICAL
- Pharmaceutical form(s)
- OINTMENT
- Ingredients
- NITROFURAZONE (0.2 G)
- Species (DPD record)
- DOGS
- Company
- WECAN SALES LTD (DIN owner)
Source and provenance
- Source dataset
- health_canada_dpd_marketed
- Source snapshot date
- Not available in this source
- Source record key
- 79745
- Archive fingerprint (SHA-256)
- 85cc3ce208af3aa57018c3d14d83f90220c436baef7455384b6d48d9774e1c88
Linked clinical reference
Clinical entries are linked through the active molecule. Check their species, formulation, source and review status separately from this product record.
Clinical evidence
Dose regimens0
No dose regimens recorded for this species selection.
Adverse effects38
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsCat
- Anorexia3 reports
- Death2 reports
- Reddening of the skin2 reports
- Surgical site disorder2 reports
- Corneal ulcer1 reports
- Dehiscence1 reports
- Application site alopecia1 reports
- Application site granuloma1 reports
- Application site scratching1 reports
- Application site ulcer1 reports
- Behavioural disorder NOS1 reports
- Conjunctivitis1 reports
Dog
- Alopecia local1 reports
- Anal sac disorder1 reports
- Application site dermatitis1 reports
- Application site hair loss1 reports
- Application site serosanguinous discharge1 reports
- Cough1 reports
- Malodour1 reports
- Moist dermatitis1 reports
- Otitis NOS1 reports
- Purulent lesion(s)1 reports
- Skin and/or appendage neoplasm NOS1 reports
- Skin lesion NOS1 reports
Literature references19
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- Depletion of semicarbazide and 5-nitrofuraldehyde in rainbow trout after nitrofurazone single oral administration.
Study summary not available in the imported record. Open the original citation to review the study.
- Ascorbate formulation promotes wound healing in goat model: Insights into molecular dynamics through cytokine modulation and angiogenic marker expression.
Study summary not available in the imported record. Open the original citation to review the study.
- In Vivo, Evaluation of Wound Healing Activity of Nanoliposomes Loaded Withania somnifera Extract.
Study summary not available in the imported record. Open the original citation to review the study.
- Residue Depletion of Nitrofurazone Metabolites, Semicarbazide and 5-Nitro-2-Furaldehyde, in Broiler Chickens After Oral Administration.
Study summary not available in the imported record. Open the original citation to review the study.
- Exploring the Wound Healing Potential of Hispidin.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration.